儿童和青少年自身免疫性肝炎患者外周血淋巴细胞亚群变化及其临床意义探讨

doi:10.3969/j.issn.1672-5069.2020.03.013

摘要/Abstract

摘要： 目的研究儿童和青少年AIH患者外周血淋巴细胞亚群的变化及其临床意义。方法 2015年6月～2019年1月我院收治的儿童和青少年AIH患者42例和健康儿童和青少年50例,使用流式细胞仪检测外周血单个核细胞表面标志物。结果 AIH患者外周血CD4⁺T细胞百分比为53.1(42.5,57.8)%,显著高于健康人,而CD14⁺T细胞百分比为62.2(40.1,76.8)%,显著低于健康人,而两组外周血CD8⁺T细胞百分比无显著性差异【25.9(12.5,32.4)%对18.7(12.8,28.5)%,P>0.05);AIH患者外周血CD4⁺T淋巴细胞表面CD45RA、CD45RO、CCR3和CD28表达百分比分别为26.1(15.2,32.8)%、19.2(13.5,27.3)%、15.4(2.1,53.8)%和51.2(34.4,56.9)%,均显著高于健康人;AIH患者外周血CD8⁺T淋巴细胞表面CD45RA、CCR3和CD25表达百分比分别为18.0(14.1,26.8)%、1.2(0.5,3.2)%和0.6(0.3,7.8)%,显著高于健康人【分别为13.6(8.2,18.3)%、0.5(0.3,0.6)%和0.3(0.2,0.5)%, P<0.05],而外周血CD8⁺T淋巴细胞表面CD45RO表达百分比为2.7(2.3,4.8)%,显著低于健康人;AIH患者外周血CD14⁺T淋巴细胞表面CD45R0表达百分比为 34.7(16.3,57.8)%,显著低于健康人。结论外周血CD4⁺、CD8⁺和CD14⁺T 细胞比例失衡及其细胞表面分子表达异常与AIH患者发病或病情进展密切相关,值得进一步研究。

关键词: 自身免疫性肝炎, 淋巴细胞亚群, 表面分子, 儿童和青少年 , ,

Abstract: Objective The aim of this study was to investigate the change and its clinical significance of peripheral blood lymphocyte subsets in children and adolescents with autoimmune hepatitis (AIH). Methods 42 child and adolescent patients with AIH and 50 healthy children were recruited in our hospital from June 2015 through January 2019, and the peripheral blood mononuclear cell surface markers were detected by flow cytometry. Results The percentage of CD4⁺T cells in children with AIH was 53.1(42.5, 57.8)%, significantly higher than , while that of CD14⁺T cells was 62.2(40.1, 76.8)%, significantly lower than in healthy children, and there was no significant difference in percentage of CD8⁺T cells between the two groups 【25.9(12.5, 32.4)% vs. 18.7(12.8, 28.5)%, P>0.05); the percentages of CD45RA, CD45RO, CCR3 and CD28 on the surfaces of CD4⁺T cells in AIH patients were 26.1(15.2, 32.8)%, 19.2(13.5, 27.3)%, 15.4(2.1, 53.8)% and 51.2(34.4, 56.9)%, all significantly higher than in healthy children; the percentages of CD45RA, CCR3 and CD25 on the surfaces of peripheral blood CD8⁺T cells were 18.0(14.1, 26.8)%, 1.2(0.5, 3.2)% and 0.6(0.3, 7.8)%, significantly higher than 【13.6(8.2, 18.3)%, 0.5(0.3, 0.6)% and 0.3(0.2, 0.5)%, respectively, P<0.05], while that of CD45RO on the surface of CD8⁺T cells was 2.7(2.3, 4.8)%, significantly lower than in the control; the percentage of CD45R0 on the surface of CD14⁺T cells in children with AIH was 34.7(16.3, 57.8)%, much lower than in healthy children. Conclusion The imbalance of CD4⁺, CD8⁺ and CD14⁺T cells in peripheral blood and the abnormal expression of cell surface molecules are closely related to the onset or progression of AIH in young patients and deserve further study.

Key words: Autoimmune hepatitis, Peripheral blood mononuclear cells, Lymphocyte subsets, Surface molecule, Children

吴志敏,杨永煌,卞相丽. 儿童和青少年自身免疫性肝炎患者外周血淋巴细胞亚群变化及其临床意义探讨[J]. 实用肝脏病杂志, 2020, 23(3): 352-355.

Wu Zhimin,Yang Yonghuang,Bian Xiangli. Changes of CD4⁺ and CD8⁺T cells in peripheral blood in children and adolescents with autoimmune hepatitis[J]. Journal of Practical Hepatology, 2020, 23(3): 352-355.

参考文献

[1] Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31: 929-938.
[2] Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis, 2009, 29: 297-306.
[3] Mieli-Vergani G, Heller S, Jara P, et al. Autoimmune hepatitis. J Pediatr Gastroenterol Nutr, 2009, 49: 158-164.
[4] Ferreira AR, Roquete ML, Toppa NH, et al. Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis. J Pediatr Gastroenterol Nutr, 2008, 46: 65-70.
[5] Bogdanos DP, Mieli-Vergani G, Vergani D. Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis, 2009, 29: 241-253.
[6] Czaja AJ, Souto EO, Bittencourt PL, et al. Clinical distinctions and pathogenic implications of type I autoimmune hepatitis in Brazil and the United States. J Hepatol, 2002, 37:302-308.
[7] Liu PMF, Miranda DM, Fagundes EDT, et al. Autoimmune hepatitis in childhood: The role of genetic and immune factors. World J Gastroenterol, 2013, 19(28): 4455-4463.
[8] Ferri S, Longhi MS, De Molo C, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology, 2010, 52: 999-1007.
[9] Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology, 2008, 48 (1): 169-176.
[10] Dehghani SM, Haghighat M, Imanieh MH, et al. Autoimmune hepatitis in children: experiences in a tertiary center. Iran J Pediatr, 2013, 23 (3):302-308.
[11] Rojas CP, Bodicharla R, Campuzano-Zuluaga G, et al. Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents. Fetal Pediatr Pathol, 2014, 33:202–209.
[12] Cisneros JN, Rodriguez YJ. Autoimmune hepatitis in children: progression of 20 cases in northern Mexico. Revista de Gastroenterología de México, 2014, 79(4):238-243.
[13] Peiseler M, Sebode M, Franke B, et al. FOXP3⁺ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol, 2012, 57(1):125-132.
[14] Liberal R, Grant CR, Holder BS, et al. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression. Hepatology, 2015, 62(3):863-875.
[15] Gaspar K, Kukova G, Bunemann E, et al. The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation. J Dermatol Sci, 2013, 71(1): 12-21.
[16] Freutel S, Gaffal E, Zahn S, et al. Enhanced CCR5⁺/CCR3⁺ T helper cell ratio in patients with active cutaneous lupus erythematosus. Lupus, 2011, 20(12):1300-1304.
[17] Landi A, Weismuller TJ, Lankisch TO, et al. Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis. J Interf Cytok Res, 2014, 34:204-214.
[18] Manousou P, Kolios G, Valatas V, et al. Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies. Clin Exp Immunol, 2010, 162(2):337-347.
[19] Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol, 1993, 11:191-212.
[20] Liaskou E, Jeffery LE, Trivedi PJ, et al. Loss of CD28 expression by liver infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. Gastroenterology, 2014, 147:221-232.